AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Shares Up 1% – Here’s What Happened

AdvisorShares Psychedelics ETF (NYSEARCA:PSIL)’s share price shot up 1% during trading on Wednesday . The stock traded as high as $17.69 and last traded at $17.48. 5,093 shares were traded during mid-day trading, a decline of 67% from the average session volume of 15,606 shares. The stock had previously closed at $17.31.

AdvisorShares Psychedelics ETF Stock Performance

The stock has a 50-day moving average of $16.84 and a 200-day moving average of $17.95.

Institutional Investors Weigh In On AdvisorShares Psychedelics ETF

An institutional investor recently bought a new position in AdvisorShares Psychedelics ETF stock. CIBC Bancorp USA Inc. purchased a new position in shares of AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 25,019 shares of the company’s stock, valued at approximately $475,000. CIBC Bancorp USA Inc. owned approximately 2.50% of AdvisorShares Psychedelics ETF at the end of the most recent reporting period.

AdvisorShares Psychedelics ETF Company Profile

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.